Our Team

Dr, Welburn is a senior pharmaceutical executive with over 30 years of global experience in R&D, general management, and commercial roles in Biotech and Pharmaceutical companies. From 2011 to 2014 Dr. Welburn served as the General Manager of LEO Pharma Australia & New Zealand following the acquisition of Peplin by LEO Pharma.

Phil has held operational positions in the United States of increasing responsibility in sales, marketing, and administration for pharmaceutical companies such as Eli Lilly, GSK (VP Hospital Sales), Bausch Health (Vice President and General Manager for North America), and Obagi (President and CEO). Phil specializes in financial and product development strategy to maximize commercial potential and outcomes. Phil is also a practicing Registered Pharmacist.

Prof. Tam is a world-renowned leader in the field of cannabis-based solutions. He is Head of the Obesity and Metabolism Laboratory at the Hebrew University of Jerusalem and Head Director of the Multidisciplinary Center of Cannabinoid in Israel. Prof. Tam received the NCATS Director's Award from the National Institute of Health, and the Chowers Prize for Endocrinology by the Israel Endocrinology Society.

Mr. Rodriguez is a result driven industry agnostic executive with extensive knowledge across multiple geographies. He has proven experience in world-class companies as a consultant at Bain & Company and as Chief Strategy Officer in publicly traded organizations. Mr. Rodriguez serves on several Boards of Directors and Advisory Committees sharing knowledge with entrepreneurs and business stakeholders. Currently is the General Manager at family office for one of Mexico´s prominent families.